COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02281266
Recruitment Status : Unknown
Verified November 2014 by Jia Fan, Fudan University.
Recruitment status was:  Not yet recruiting
First Posted : November 2, 2014
Last Update Posted : November 21, 2014
SciClone Pharmaceuticals
Information provided by (Responsible Party):
Jia Fan, Fudan University